Belmar Select Outsourcing
Belmar Select Outsourcing is an FDA-registered 503B outsourcing facility that compound manufactures sterile bioidentical hormone pellets and testosterone injectable blends for direct office-use distribution to healthcare prescribers across 48 states.
- Company typePrivate
- Founded-
- HeadquartersGolden, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Belmar Select Outsourcing does
Belmar Select Outsourcing is an FDA-registered 503B outsourcing facility operating within the Belmar Pharma Solutions network (owned by Belmar Midco, Inc.) that compound manufactures sterile bioidentical hormone replacement therapy (BHRT) products in large, non-patient-specific batches for direct office-use distribution to healthcare prescribers. The company runs two production sites in Golden and Lakewood, Colorado, equipped with state-of-the-art clean rooms and e-beam radiation terminal sterilization, and produces sterile hormone pellets (estradiol, testosterone, anastrozole) plus injectable testosterone cypionate blends combined with DHEA or anastrozole in grapeseed oil. Its portfolio is licensed to ship to 48 states and Washington D.C., with a California Sterile License and additional regulatory credentials (NABP, LegitScript, cGMP, DEA oversight for controlled substances), and 100% weight testing, visual inspection, and independent third-party testing are embedded in the release process.
The business sells on a quote-based, no-contract, pay-as-you-go basis to clinicians who maintain office inventory of these compounded medications, enabling in-office pellet insertion and injectable hormone therapy without patient-specific prescriptions. Go-to-market is enterprise field sales plus inside account-based ordering, supported by Solutions Engineers, on-call clinical pharmacists, free clinician webinars, and telemedicine support resources. Marketing is executed through clinical content, email newsletters, and organic social (LinkedIn, Facebook).
The 503B regulatory classification is the defining structural feature of the business model: it permits large-batch office-use compounding under cGMP rather than the patient-specific 503A framework, which is the principal lever differentiating Belmar Select Outsourcing from traditional compounding pharmacies. The company carries 129 employees and ships directly to prescriber offices, often with same-day-next-day fulfillment when inventory is available. No public revenue, funding rounds, M&A, or leadership-change data is disclosed in available material.
Belmar Select Outsourcing firmographics
Firmographics- Name
- Belmar Select Outsourcing
- Legal name
- Belmar Select Outsourcing
- Website
- https://belmarselectoutsourcing.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Belmar Select Outsourcing is an FDA-registered 503B outsourcing facility that compound manufactures sterile bioidentical hormone pellets and testosterone injectable blends for direct office-use distribution to healthcare prescribers across 48 states.
- Ownership category
- akta.pro rank
Belmar Select Outsourcing industry classification
Industry- Product category
- Compounding Pharmacy Manufacturing (503B Outsourcing Facility)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Central Fill & Pharmacy Outsourcing Services (HLAFALAM)
- akta.pro secondary industry
- Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)
Keywords
Where Belmar Select Outsourcing is headquartered
LocationHeadquarters
- HQ city
- Golden
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Belmar Select Outsourcing business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Office-Use Compounded Medications: Belmar Select Outsourcing generates revenue by selling compound manufactured sterile hormone pellets and injectable testosterone blends in large-scale quantities for direct distribution to prescribers. Products are non-patient-specific office-use medications that can be shipped directly to prescriber offices or healthcare facilities. Revenue is transaction-based as prescribers order medications for their practice inventory.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for office-use compounded medications |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Belmar Select Outsourcing product offering
Product offeringCore offering
Belmar Select Outsourcing is a 503B outsourcing facility that compound manufactures sterile bioidentical hormone pellets and sterile injectable testosterone cypionate blends in large-scale quantities for direct distribution to prescribers. Products are non-patient-specific office-use medications shipped directly to clinician offices, with manufacturing supported by clean room facilities, e-beam radiation terminal sterilization, 100% weight testing, visual inspection, and independent third-party testing under FDA-enforced CGMP requirements.
Product overview
Belmar Select Outsourcing is a national 503B outsourcing facility that compound manufactures sterile bioidentical hormone pellets and sterile injectable testosterone cypionate blends in large-scale quantities for direct distribution to prescribers. The product portfolio includes testosterone pellets, estradiol pellets, and anastrozole pellets (as hormone pellet implants), as well as injectable blends combining testosterone cypionate with DHEA or anastrozole in grapeseed oil. Products are designed for office-use and shipped directly to prescriber offices or healthcare facilities, with licensing to ship to 48 states including Washington D.C.
Differentiator
Problem solved
Functional benefit
Products and services
- Testosterone Pellets Sterile bioidentical testosterone hormone pellets for in-office insertion; each pellet is 100% weight tested, visually inspected, packaged in glass vials, and terminally sterilized via e-beam radiation. Designed for healthcare prescribers and clinicians to maintain office-use supply for hormone replacement therapy.
- Estradiol Pellets Sterile bioidentical estradiol hormone pellets for in-office insertion in women; terminally sterilized via e-beam radiation and intended for non-patient-specific office-use supply to prescribers.
- Anastrozole Pellets Sterile anastrozole hormone pellets for in-office insertion; terminally sterilized via e-beam radiation and supplied as non-patient-specific office-use compounded medication.
- Testosterone Cypionate/DHEA Injectable Blend Combination injectable blend of testosterone cypionate and DHEA in grapeseed oil for office-use administration. Each vial is 100% visually inspected for particulates and terminally sterilized via e-beam radiation.
- Testosterone Cypionate/Anastrozole Injectable Blend Combination injectable blend of testosterone cypionate and anastrozole in grapeseed oil for office-use administration. Each vial is 100% visually inspected for particulates and terminally sterilized via e-beam radiation.
- Testosterone Compounded Medication (503B) Bioidentical testosterone hormone for hormone replacement therapy, available as sterile injectable and pellet formulations compounded in a 503B outsourcing facility for office-use supply to prescribers and clinician offices.
Quantifiable outcome
- Pellets 100% weight tested and visually inspected before terminal e-beam radiation sterilization
- +2 more outcomes
Companies that use Belmar Select Outsourcing
Customer profileSegments1 record
Ideal customer profiles1 record
Belmar Select Outsourcing technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Belmar Select Outsourcing partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Belmar Select Outsourcing competitors and assessment
Company assessmentDirect peers
- Leiters: 503B outsourcing facility providing ready-to-administer sterile compounded preparations including injectables. Directly comparable as a CGMP-registered 503B outsourcer focused on sterile preparations for healthcare providers.
- SCA Pharma: 503B outsourcing facility producing sterile injectable medications and pre-filled syringes for hospitals and healthcare facilities. Comparable as a CGMP-registered 503B manufacturer serving the same prescriber and institutional customer base with sterile compounded products.
- Wells Pharmacy Network: National 503A and 503B compounding pharmacy offering customized sterile preparations including bioidentical hormone therapy. Directly comparable as a multi-state compounder serving prescribers and patients with hormone pellets and injectables.
- QuVa Pharma: National 503B outsourcing facility specializing in sterile injectable preparations with CGMP-compliant manufacturing. Directly comparable as a 503B outsourcer serving hospitals and clinics with compounded sterile injectables, though QuVa's portfolio is broader across therapeutic categories.
- AnazaoHealth: National 503A and 503B compounding pharmacy offering sterile and non-sterile compounded medications. Comparable as a multi-state compounder serving prescribers with hormone therapy and other specialty preparations.
- Empower Pharmacy: Largest 503A and 503B compounding pharmacy in the U.S., offering custom-compounded sterile and non-sterile medications including hormone therapy. Directly comparable as a multi-state outsourcing facility serving prescribers with bioidentical hormone pellets and injectables.
- ImprimisRx: 503A compounding pharmacy specializing in custom-compounded medications including hormone therapy. Comparable as a national compounder focused on personalized prescriptions, though operating under 503A rather than 503B framework.
- Pentec Health: 503B outsourcing facility providing sterile compounded medications and home infusion services nationally. Comparable as a CGMP-registered 503B manufacturer serving physician offices and institutional customers with sterile compounded products.
Others
- PCCA (Professional Compounding Centers of America): Industry resource and supplier supporting independent compounding pharmacies with APIs, bases, equipment, and training. Adjacent to Belmar as an enabler of the compounding ecosystem rather than a direct manufacturer, but operates in the same compounded medications supply chain.
Broad incumbents
- Fagron: Global leader in pharmaceutical compounding with broad portfolio of APIs, bases, and compounded preparations across therapeutic categories. Comparable as a larger incumbent serving compounding pharmacies and prescribers, though Fagron operates more as a supplier and broader compounder.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Belmar Select Outsourcing social profiles
Digital presenceBelmar Select Outsourcing compliance and trust
Trust signalCompliance5 records
Belmar Select Outsourcing financial estimates
Financial estimateRevenue estimate
Valuation estimate
Belmar Select Outsourcing leadership team
Management profileNumber of profiles
Belmar Select Outsourcing funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Belmar Select Outsourcing M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Belmar Select Outsourcing
What does Belmar Select Outsourcing do?
Belmar Select Outsourcing is a 503B outsourcing facility that compound manufactures sterile bioidentical hormone pellets and sterile injectable testosterone cypionate blends in large-scale quantities for direct distribution to prescribers. Products are non-patient-specific office-use medications shipped directly to clinician offices, with manufacturing supported by clean room facilities, e-beam radiation terminal sterilization, 100% weight testing, visual inspection, and independent third-party testing under FDA-enforced CGMP requirements.
Is Belmar Select Outsourcing a public or private company?
Belmar Select Outsourcing is a private company. It is classified as corporate owned and is currently operating.
When was Belmar Select Outsourcing founded?
Belmar Select Outsourcing was founded in -1. It employs 101 to 250 people.
Where is Belmar Select Outsourcing based?
Belmar Select Outsourcing is headquartered in Golden, United States, in the North America region.
How does Belmar Select Outsourcing make money?
One revenue line is on record: office-Use Compounded Medications.
Who are Belmar Select Outsourcing's main competitors?
Direct peers on record are Leiters, SCA Pharma, Wells Pharmacy Network, QuVa Pharma, AnazaoHealth, Empower Pharmacy, ImprimisRx and Pentec Health. PCCA (Professional Compounding Centers of America) is listed as an others. Fagron is listed as a broad incumbent.
Does Belmar Select Outsourcing have an API?
No public API is recorded for Belmar Select Outsourcing.
What industry is Belmar Select Outsourcing in?
Belmar Select Outsourcing's product category is Compounding Pharmacy Manufacturing (503B Outsourcing Facility). Its primary akta.pro industry code is HLAFALAM, Central Fill & Pharmacy Outsourcing Services, with a secondary code of HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.